Prosthetic Innovations Limited 06455444 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is Medical training Digita Accounts Production Advanced 6.30.9574.0 true 06455444 2025-01-01 2025-12-31 06455444 2025-12-31 06455444 bus:Director1 1 2025-12-31 06455444 core:RetainedEarningsAccumulatedLosses 2025-12-31 06455444 core:ShareCapital 2025-12-31 06455444 core:CurrentFinancialInstruments 2025-12-31 06455444 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 06455444 core:LandBuildings core:LongLeaseholdAssets 2025-12-31 06455444 core:OfficeEquipment 2025-12-31 06455444 core:PlantMachinery 2025-12-31 06455444 bus:SmallEntities 2025-01-01 2025-12-31 06455444 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 06455444 bus:FilletedAccounts 2025-01-01 2025-12-31 06455444 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 06455444 bus:RegisteredOffice 2025-01-01 2025-12-31 06455444 bus:Director1 2025-01-01 2025-12-31 06455444 bus:Director1 1 2025-01-01 2025-12-31 06455444 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 06455444 bus:Agent1 2025-01-01 2025-12-31 06455444 core:ComputerEquipment 2025-01-01 2025-12-31 06455444 core:LandBuildings core:LongLeaseholdAssets 2025-01-01 2025-12-31 06455444 core:LeaseholdImprovements 2025-01-01 2025-12-31 06455444 core:OfficeEquipment 2025-01-01 2025-12-31 06455444 core:PlantMachinery 2025-01-01 2025-12-31 06455444 countries:AllCountries 2025-01-01 2025-12-31 06455444 2024-12-31 06455444 bus:Director1 1 2024-12-31 06455444 core:LandBuildings core:LongLeaseholdAssets 2024-12-31 06455444 core:OfficeEquipment 2024-12-31 06455444 core:PlantMachinery 2024-12-31 06455444 2024-01-01 2024-12-31 06455444 2024-12-31 06455444 bus:Director1 1 2024-12-31 06455444 core:RetainedEarningsAccumulatedLosses 2024-12-31 06455444 core:ShareCapital 2024-12-31 06455444 core:CurrentFinancialInstruments 2024-12-31 06455444 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 06455444 core:LandBuildings core:LongLeaseholdAssets 2024-12-31 06455444 core:OfficeEquipment 2024-12-31 06455444 core:PlantMachinery 2024-12-31 06455444 bus:Director1 2024-01-01 2024-12-31 06455444 bus:Director1 1 2024-01-01 2024-12-31 06455444 bus:Director1 1 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 06455444

Prosthetic Innovations Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2025

Prosthetic Innovations Limited

Contents

Company Information | 1
Profit and Loss Account and Statement of Retained Earnings | 2
Statement of Financial Position | 3
Notes to the Unaudited Financial Statements | 4 to 10

Prosthetic Innovations Limited

Company Information

Director | Miss Jane McPhail

Registered office | Birch House Oram Road Brindle Chorley Lancashire PR6 8NT

Accountants | McDade Roberts Accountants Ltd Chartered Accountants316 Blackpool Road Preston Lancashire PR2 3AE

Prosthetic Innovations Limited

Profit and Loss Account and Statement of Retained Earnings for the Year Ended 31 December 2025

| Note | 2025 £ | 2024 £
Turnover |  | 210,573 | 335,995
Cost of sales |  | (31) | -
Gross profit |  | 210,542 | 335,995
Administrative expenses |  | (41,308) | (41,288)
Other operating income |  | 300 | -
Operating profit |  | 169,534 | 294,707
Other interest receivable and similar income |  | 1,132 | 1,170
|  | 1,132 | 1,170
Profit before tax |  | 170,666 | 295,877
Taxation |  | (42,854) | (74,240)
Profit for the financial year |  | 127,812 | 221,637
Retained earnings brought forward |  | 277,601 | 699,757
Dividends paid |  | (49,208) | (643,793)
Retained earnings carried forward |  | 356,205 | 277,601

Prosthetic Innovations Limited

(Registration number: 06455444)
Statement of Financial Position as at 31 December 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 2,425 | 1,883
Current assets |  |  |
Debtors | 6 | 54,840 | 54,935
Cash at bank and in hand |  | 351,579 | 303,687
|  | 406,419 | 358,622
Creditors: Amounts falling due within one year | 7 | (51,863) | (82,263)
Net current assets |  | 354,556 | 276,359
Total assets less current liabilities |  | 356,981 | 278,242
Provisions for liabilities |  | (606) | (471)
Net assets |  | 356,375 | 277,771
Capital and reserves |  |  |
Called up share capital |  | 170 | 170
Retained earnings |  | 356,205 | 277,601
Shareholders' funds |  | 356,375 | 277,771

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the director on 6 March 2026

......................................... Miss Jane McPhail Director

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Birch House
Oram Road
Brindle
Chorley
Lancashire
PR6 8NT

These financial statements were authorised for issue by the director on 6 March 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

2 | Accounting policies (continued)

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Improvements to property | 20% on Cost
Plant & Machinery | 33% on Cost
Computer equipment | 33% on Cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

4 | Tangible assets

| Improvements to Property £ | Plant and machinery £ | Office equipment £ | Total £
Cost or valuation
At 1 January 2025 | 5,100 | 4,740 | 20,198 | 30,038
Additions | - | - | 3,278 | 3,278
Disposals | - | - | (1,166) | (1,166)
At 31 December 2025 | 5,100 | 4,740 | 22,310 | 32,150
Depreciation
At 1 January 2025 | 5,100 | 4,740 | 18,315 | 28,155
Charge for the year | - | - | 1,955 | 1,955
Eliminated on disposal | - | - | (385) | (385)
At 31 December 2025 | 5,100 | 4,740 | 19,885 | 29,725
Carrying amount
At 31 December 2025 | - | - | 2,425 | 2,425
At 31 December 2024 | - | - | 1,883 | 1,883

5 | Investment properties

| 2025 £

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 54,618 | 46,320
Prepayments | 221 | 391
Other debtors | 1 | 8,224
| 54,840 | 54,935

7 | Creditors

Creditors: amounts falling due within one year

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

7 | Creditors (continued)

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 51,005 | 81,412
Accruals and deferred income | 850 | 850
Other creditors | 8 | 1
| 51,863 | 82,263

8 | Related party transactions

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

8 | Related party transactions (continued)

Transactions with the director

2025 | At 1 January 2025 £ | Advances to director £ | Repayments by director £ | At 31 December 2025 £
Miss Jane McPhail
Directors' Loan Account | 8,222 | 279 | (8,510) | (9)

2024 | At 1 January 2024 £ | Advances to director £ | Repayments by director £ | At 31 December 2024 £
Miss Jane McPhail
Directors' Loan Account | (206,300) | 271,562 | (57,040) | 8,222

Prosthetic Innovations Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

8 | Related party transactions (continued)

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not disclose related party transactions with wholly owned subsidiaries within the group.

9 | Ultimate Controlling Party

The controlling party is McPhail Holdings Limited